Nifty Reclaims 23,000 as IT and Pharma Rally; Trent, IndiGo Jump on Q2 Results

How IT and Pharma Lifted the Nifty Back Above 23,000

Indian equity benchmarks closed higher on October 30, 2026, extending gains for a second straight session. The Nifty 50 rose 116.35 points, or 0.51%, to 23,053.10, reclaiming the 23,000 level, while the Sensex added 308.49 points, or 0.42%, to end at 74,459.53. The advance was driven by two sectors: information technology, where Nifty IT climbed 2.32%, and pharmaceuticals, where Nifty Pharma rose 1.55% after touching a record high of 27,263.95 during the session.

The IT move followed Cognizant's quarterly results and a rotation into Indian technology stocks as an AI-related selloff hit Asian markets, with South Korea's Kospi down 3.61% and Japan's Nikkei down 2.52% after weak results from Alphabet, Amazon and Intel. Infosys gained 3.36% and contributed roughly 30 points to the Sensex, second only to HDFC Bank. Pharma strength came from CDMO names such as Laurus Labs and Piramal Pharma, while Sun Pharma advanced after the US FDA approved Ilumya for psoriatic arthritis.

Two earnings reactions stood out. Trent surged 5.44% after reporting a 25% year-on-year rise in consolidated net profit to Rs 468 crore for Q2 FY27, with revenue up 22% to Rs 5,873 crore and EBITDA up 37% to Rs 785 crore. IndiGo gained 4.33% as its net loss narrowed to Rs 1,878.6 crore from Rs 2,581.7 crore a year earlier, with revenue up 25.9% to Rs 23,363.8 crore and EBITDA nearly doubling to Rs 1,907 crore.

The rally was nonetheless narrow. Nifty Bank slipped 0.41% to 54,686.95, eight of thirteen sectoral indices ended lower, and the Nifty Midcap 100 and Smallcap 100 fell 0.93% and 1.85% respectively. Domestic institutional investors bought Rs 1,924 crore of equities on Thursday, more than offsetting foreign institutional selling of Rs 944 crore, while a softer US 10-year yield near 4.90% and a firmer rupee at about 95.19 supported sentiment against crude oil near $113 per barrel.

Inside a Narrow Rally: Rotation, Earnings and the Bank Drag

Why the IT Rotation Mattered More Than the Index Move

The 2.32% jump in Nifty IT was not a sector upgrade story; it was a rotation story. As an AI-linked selloff dragged Asian technology benchmarks lower, investors moved into Indian IT names that had already de-rated sharply. Infosys, up 3.36%, remains roughly 27% lower year-to-date and trades below its 200-day moving average, a level the article identifies as technical resistance. That combination — a sharp bounce inside a longer downtrend — means the move reflects positioning and sentiment after Cognizant's results rather than a change in the sector's earnings trajectory. Wipro and Coforge rose more than 4%, and HCLTech also advanced, suggesting the buying was broad within IT but shallow in conviction.

Trent's Margin Story Is the Durable Signal

Trent's 5.44% gain rested on more than the headline 25% profit increase. Gross margin improved 121 basis points to 44.5% and operating EBITDA grew 37% to Rs 785 crore — faster than the 22% revenue growth — which indicates operating leverage rather than purely top-line expansion. Store counts (311 Westside and 999 Zudio) and emerging categories such as beauty, innerwear and footwear contributing over 21% of revenue point to a retail model widening beyond apparel. Star's revenue growth recovering to 20% after five quarters of slower growth is arguably the most important line in the release. The caveats: standalone profit rose only 9% to Rs 490 crore with employee costs up 36%, and Nuvama trimmed its target price to Rs 3,466 from Rs 3,591 even while keeping a Buy rating — a signal that the market is rewarding execution but not raising its valuation ceiling.

IndiGo Is Trading Pricing Power Against Volume Loss

IndiGo's narrower loss came with a clear strategic choice: management said it will prioritise pricing over capacity, guiding PRASK up more than 25% in Q3 and FY27 while keeping capacity growth in low single digits. The arithmetic is demanding. ATF expense rose 67% to Rs 9,967 crore and passenger numbers fell 4.7%, and Nomura estimated pricing is capturing only 80–90% of cost inflation. EBITDA nearly doubling to Rs 1,907 crore with margins up over 500 basis points shows the pricing strategy is working so far, but it depends on sustained fare discipline in a market where volume is already contracting. Jefferies and Nomura retained Buy ratings while UBS stayed Neutral — the split reflects exactly this tension.

Shriram Finance Shows Where the Stress Is Building

The 2.13% fall in Shriram Finance was not an earnings miss — Q2 profit rose nearly 60% to about Rs 3,677 crore, ahead of expectations. The stock fell because management cut FY27 AUM growth guidance to 15–17% from 18%, citing weak monsoon conditions and geopolitical uncertainty, and warned of higher credit costs and borrower stress in drought-hit regions. Jefferies said credit costs could stay elevated for one to two more quarters. Rising stress in Maharashtra, Karnataka and Telangana is a rural-demand signal that sits awkwardly alongside the benchmark's gains, and it helps explain why Nifty Bank fell 0.41% even as the Nifty rose.

What the Narrow Breadth Actually Says

Eight of thirteen sectoral indices closed lower, Nifty Media fell 1.46%, and the smallcap index dropped 1.85%. A rally carried by two sectors and two earnings reactions, funded partly by domestic institutional buying of Rs 1,924 crore against FII selling of Rs 944 crore, is a rotation rather than a broad re-rating. The macro supports — US 10-year yield near 4.90%, rupee firmer at 95.19, and the Fed, ECB and Bank of Japan all holding rates — are real but external. For context, crude near $113 per barrel remains a structural headwind for an economy that imports most of its oil, and it weighs on aviation, paints, tyres and other input-cost-sensitive sectors even on days when the index rises.

What the Session Signals for Indian Equity Positioning

The session's real message is that leadership has narrowed to IT and pharma while banks, energy and smallcaps weaken — a rotation trade, not a broad recovery.

• Treat the IT bounce as tactical until Infosys clears its 200-day moving average. Infosys is still down about 27% year-to-date and added roughly 30 Sensex points on October 30; the 200-day level is the specific technical barrier the article flags as resistance.
• Watch IndiGo's Q3 PRASK print against its 4.7% passenger decline. Management guided PRASK up over 25% with low-single-digit capacity growth; Nomura's estimate that pricing covers only 80–90% of cost inflation, with ATF up 67% to Rs 9,967 crore, is the number that determines whether the margin expansion holds.
• Track Shriram Finance's credit costs over the next one to two quarters. Jefferies expects elevated credit costs, and stress is concentrated in Maharashtra, Karnataka and Telangana — a read-across for rural-facing lenders and NBFCs.
• For Trent, focus on Star's 20% revenue recovery and the 44.5% gross margin. Employee costs up 36% and Nuvama's trimmed target of Rs 3,466 (from Rs 3,591) show the market is pricing execution, not multiple expansion.

Metrics to watch: FII versus DII flow data (Rs 1,924 crore bought versus Rs 944 crore sold on Thursday), the US 10-year yield around 4.90%, the rupee near 95.19, crude near $113 per barrel, and whether Nifty Bank can reverse its 0.41% decline — banking weakness is the clearest constraint on the index holding above 23,000.